RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgeryCentral Message - Charles A. Mack, MD; Michael Jessen, MD; Andre Lamy, MD; Ashish K. Khanna, MD; Kevin Lobdell, MD; Rakesh Arora, MD; Jeannette Rodriguez, PhD; Stacey Ruiz, PhD; Bhupinder Singh, MD (JTCVS Open, 2024)